Induction of endothelin-2 expression by luteinizing hormone and hypoxia: Possible role in bovine corpus luteum formation

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1914-1922

  Klipper, Eyal ^a   Levit, Anat ^a   Mastich, Yonit ^a   Berisha, Bajram ^b   Schams, Dieter ^b   Meidan, Rina ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; CYCLOOXYGENASE 2; ENDOTHELIN 2; LUTEINIZING HORMONE; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS LUTEUM; COW; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; LUTEAL CELL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANOXIA; BLOTTING, WESTERN; CATTLE; CELL PROLIFERATION; CELLS, CULTURED; COBALT; CORPUS LUTEUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-2; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GONADOTROPIN-RELEASING HORMONE; GRANULOSA CELLS; LUTEINIZING HORMONE; OVARIAN FOLLICLE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950226276     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0767     Document Type: Article

References (58)

1. Arinami T, Ishikawa M, Inoue A, Yanagisawa M, Masaki T, Yoshida MC, Hamaguchi H 1991 Chromosomal assignments of the human endothelin family genes: the endothelin-1 gene (EDN1) to 6p23-p24, the endothelin-2 gene (EDN2) to 1p34, and the endothelin-3 gene (EDN3) to 20q13.2-q13.3. Am J Hum Genet 48:990-996
2. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T 1989 The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867
3. Turner AJ, Murphy LJ 1996 Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51:91-102
4. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M1994 ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485
5. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB 1999 A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264:341-349
6. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P, Tougard C 2003 Heterodimerization of endothelin-converting enzyme- 1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 278:545-555
7. Emoto N, Nurhantari Y, Alimsardjono H, Xie J, Yamada T, Yanagisawa M, Matsuo M 1999 Constitutive lysosomal targeting and degradation of bovine endothelin-converting enzyme-1a mediated by novel signals in its alternatively spliced cytoplasmic tail. J Biol Chem 274:1509-1518
8. Meidan R, Klipper E, Gilboa T, Muller L, Levy N 2005 Endothelin- converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J Biol Chem 280:40867-40874
9. Korth P, Bohle RM, Corvol P, Pinet F 1999 Cellular distribution of endothelin-converting enzyme-1 in human tissues. J Histochem Cytochem 47:447-462
10. Levy N, Gordin M, Smith MF, Bolden-Tiller OU, Meidan R 2003 Hormonal regulation and cell-specific expression of endothelin-converting enzyme 1 isoforms in bovine ovarian endothelial and steroidogenic cells. Biol Reprod 68:1361-1368
11. Egidy G, Baviera E, Ciuffo G, Corvol P, Pinet F 2001 Localization of the endothelin system in aldosterone-producing adenomas. Hypertension 38:1137-1142
12. Saida K, Kometani N, Uchide T, Mitsui Y 2002 Sequence analysis and expression of the mouse full-length vasoactive intestinal contractor/ endothelin-2 gene (EDN2): comparison with the endothelin-1 gene (EDN1). Clin Sci (Lond) 103(Suppl 48):84S-89S
13. Bertram R, Tabak J, Toporikova N, Freeman ME 2006 Endothelin action on pituitary lactotrophs: one receptor, many GTP-binding proteins. Sci STKE 2006:er2
14. Meidan R, Levy N 2002 Endothelin-1 receptors and biosynthesis in the corpus luteum: molecular and physiological implications. Domest Anim Endocrinol 23:287-298
15. Rossi GP, Belloni AS, Nussdorfer GG, Pessina AC 2000 Endothelin-1 and the adrenal gland. J Cardiovasc Pharmacol 35:S17-S20
16. Schams D, Berisha B, Neuvians T, Amselgruber W, Kraetzl WD 2003 Real-time changes of the local vasoactive peptide systems (angiotensin, endothelin) in the bovine corpus luteum after induced luteal regression. Mol Reprod Dev 65:57-66
17. Choudhary E, Costine BA, Wilson ME, Inskeep EK, Flores JA 2004 Prostaglandin F2α(PGF2α) independent and dependent regulation of the bovine luteal endothelin system. Domest Anim Endocrinol 27:63-79
18. Kobayashi S, Acosta T, Hayashi K, Berisha B, Ozawa T, Ohtani M, Schams D, Miyamoto A 2002 Intraluteal release of prostaglandin F2α and E2 during corpora lutea development in the cow. J Reprod Dev 48:583-590
19. Shirasuna K, Asaoka H, Acosta TJ, Wijayagunawardane MP, Matsui M, Ohtani M, Miyamoto A 2004 Endothelin-1 within the corpus luteum during spontaneous luteolysis in the cow: local interaction with prostaglandin F2α and angiotensin II. J Cardiovasc Pharmacol 44(Suppl 1):S252-S255
20. Meidan R, Levy N 2007 The ovarian endothelin network: an evolving story. Trends Endocrinol Metab 18:379-385
21. Na G, Bridges PJ, Koo Y, Ko C 2008 Role of hypoxia in the regulation of periovulatory EDN2 expression in the mouse. Can J Physiol Pharmacol 86:310-319
22. Grimshaw MJ, Hagemann T, Ayhan A, Gillett CE, Binder C, Balkwill FR 2004 A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 64:2461-2468
23. Kim J, Bagchi IC, Bagchi MK 2009 Signaling by hypoxia-inducible factors is critical for ovulation in mice. Endocrinology 150:3392-3400
24. Grimshaw MJ, Naylor S, Balkwill FR 2002 Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. Mol Cancer Ther 1:1273-1281
25. Kotake-Nara E, Saida K 2007 Characterization of CoCl2-induced reactive oxygen species (ROS): inductions of neurite outgrowth and endothelin-2/ vasoactive intestinal contractor in PC12 cells by CoCl2 are ROS dependent, but those by MnCl2 are not. Neurosci Lett 422:223-227
26. Ko C, Gieske MC, Al-Alem L, Hahn Y, Su W, Gong MC, Iglarz M, Koo Y 2006 Endothelin-2 in ovarian follicle rupture. Endocrinology 147:1770-1779
27. Palanisamy GS, Cheon YP, Kim J, Kannan A, Li Q, Sato M, Mantena SR, Sitruk-Ware RL, Bagchi MK, Bagchi IC 2006 A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. Mol Endocrinol 20:2784-2795
28. Berisha B, Welter H, Shimizu T, Miyamoto A, Meyer HH, Schams D 2006 Expression of fibroblast growth factor 1 (FGF1) and FGF7 in mature follicles during the periovulatory period after GnRH in the cow. J Reprod Dev 52:307-313
29. Meidan R, Girsh E, Blum O, Aberdam E 1990 In vitro differentiation of bovine theca and granulosa cells into small and large luteal-like cells: morphological and functional characteristics. Biol Reprod 43:913-921
30. Kisliouk T, Levy N, Hurwitz A, Meidan R 2003 Presence and regulation of endocrine gland vascular endothelial growth factor/prokineticin-1 and its receptors in ovarian cells. J Clin Endocrinol Metab 88:3700-3707
31. Lie BL, Leung E, Leung PC, Auersperg N 1996 Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen. Mol Cell Endocrinol 120:169-176
32. Fields MJ, Fields PA 1996 Morphological characteristics of the bovine corpus luteum during the estrous cycle and pregnancy. Theriogenology 45:1295-1325
33. Levy N, Gordin M, Mamluk R, Yanagisawa M, Smith MF, Hampton JH, Meidan R 2001 Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis. Endocrinology 142:5254-5260
34. Klipper E, Tatz E, Kisliouk T, Vlodavsky I, Moallem U, Schams D, Lavon Y, Wolfenson D, Meidan R 2009 Induction of heparanase in bovine granulosa cells by luteinizing hormone: possible role during the ovulatory process. Endocrinology 150:413-421
35. Rayhman O, Klipper E, Muller L, Davidson B, Reich R, Meidan R 2008 Small interfering RNA molecules targeting endothelin-converting enzyme-1 inhibit endothelin-1 synthesis and the invasive phenotype of ovarian carcinoma cells. Cancer Res 68:9265-9273
36. Kaczmarek MM, Kowalczyk AE, Waclawik A, Schams D, Ziecik AJ 2007 Expression of vascular endothelial growth factor and its receptors in the porcine corpus luteum during the estrous cycle and early pregnancy. Mol Reprod Dev 74:730-739
37. Bridges PJ, Komar CM, Fortune JE 2006 Gonadotropin-induced expression of messenger ribonucleic acid for cyclooxygenase-2 and production of prostaglandins E and F2α in bovine preovulatory follicles are regulated by the progesterone receptor. Endocrinology 147:4713-4722
38. Hayashi K, Acosta TJ, Berisha B, Kobayashi S, Ohtani M, Schams D, Miyamoto A 2003 Changes in prostaglandin secretion by the regressing bovine corpus luteum. Prostaglandins Other Lipid Mediat 70:339-349
39. Robker RL, Russell DL, Yoshioka S, Sharma SC, Lydon JP, O'Malley BW, Espey LL, Richards JS 2000 Ovulation: a multi-gene, multi-step process. Steroids 65:559-570
40. Shimizu T, Berisha B, Schams D, Miyamoto A 2007 Changes in the messenger RNA expressions of the endothelin-1 and angiotensin systems in mature follicles of the superovulated bovine ovary. J Reprod Dev 53:655-662
41. Smith MF, McIntush EW, Ricke WA, Kojima FN, Smith GW 1999 Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. J Reprod Fertil Suppl 54:367-381
42. Tesone M, Stouffer RL, Borman SM, Hennebold JD, Molskness TA 2005 Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective messenger RNA expression in vivo and hypoxia-regulated protein secretion in vitro. Biol Reprod 73:927-934
43. Lee A, Christenson LK, Patton PE, Burry KA, Stouffer RL 1997 Vascular endothelial growth factor production by human luteinized granulosa cells in vitro. Hum Reprod 12:2756-2761
44. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R 2000 Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reprod 63:1106-1114
45. Redmer DA, Dai Y, Li J, Charnock-Jones DS, Smith SK, Reynolds LP, Moor RM 1996 Characterization and expression of vascular endothelial growth factor (VEGF) in the ovine corpus luteum. J Reprod Fertil 108:157-165
46. Hazzard TM, Christenson LK, Stouffer RL 2000 Changes in expression of vascular endothelial growth factor and angiopoietin-1 and -2 in the macaque corpus luteum during the menstrual cycle. Mol Hum Reprod 6:993-998
47. Berisha B, Steffl M, Welter H, Kliem H, Meyer HH, Schams D, Amselgruber W 2008 Effect of the luteinising hormone surge on regulation of vascular endothelial growth factor and extracellular matrix-degrading proteinases and their inhibitors in bovine follicles. Reprod Fertil Dev 20:258-268
48. Lin C, McGough R, Aswad B, Block JA, Terek R 2004 Hypoxia induces HIF-1α and VEGF expression in chondrosarcoma cells and chondrocytes. J Orthop Res 22:1175-1181
49. Horiuchi A, Imai T, Shimizu M, Oka K, Wang C, Nikaido T, Konishi I 2002 Hypoxia-induced changes in the expression of VEGF, HIF-1α and cell cycle-related molecules in ovarian cancer cells. Anticancer Res 22:2697-2702
50. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Giaccia AJ 2000 Candidate genes for the hypoxic tumor phenotype. Cancer Res 60:883-887
51. Schoeffter P, Randriantsoa A, Jost B, Bruttel K 1993 Comparative effects of the two endothelin ETA receptor antagonists, BQ-123 and FR139317, on endothelin-1-induced contraction in guinea-pig iliac artery. Eur J Pharmacol 241:165-169
52. Rodgers RJ, Mitchell MD, Simpson ER 1988 Secretion of progesterone and prostaglandins by cells of bovine corpora lutea from three stages of the luteal phase. J Endocrinol 118:121-126
53. Milvae RA, Hansel W 1983 Prostacyclin, prostaglandin F2 alpha and progesterone production by bovine luteal cells during the estrous cycle. Biol Reprod 29:1063-1068
54. Mamluk R, Defer N, Hanoune J, Meidan R 1999 Molecular identification of adenylyl cyclase 3 in bovine corpus luteum and its regulation by prostaglandin F2α-induced signaling pathways. Endocrinology 140:4601-4608
55. Girsh E, Greber Y, Meidan R 1995 Luteotrophic and luteolytic interactions between bovine small and large luteal-like cells and endothelial cells. Biol Reprod 52:954-962
56. Miyamoto A, von Lützow H, Schams D 1993 Acute actions of prostaglandin F2α, E2, and I2 in microdialyzed bovine corpus luteum in vitro. Biol Reprod 49:423-430
57. Sargent EL, Baughman WL, Novy MJ, Stouffer RL 1988 Intraluteal infusion of a prostaglandin synthesis inhibitor, sodium meclofenamate, causes premature luteolysis in rhesus monkeys. Endocrinology 123:2261-2269
58. Fulghesu AM, Lanzone A, Di Simone N, Nicoletti MC, Caruso A, Mancuso S 1993 Indomethacin in vivo inhibits the enhancement of the progesterone secretion in response to gonadotrophin-releasing hormone by human corpus luteum. Hum Reprod 8:35-39